dc.contributor.author
Boladeras i Cucurella, Margarida
dc.date.issued
2019-01-22T09:09:26Z
dc.date.issued
2019-01-22T09:09:26Z
dc.date.issued
2019-01-22T09:09:26Z
dc.identifier
https://hdl.handle.net/2445/127497
dc.description.abstract
Genomics research and its application to next-generation drug design has made significant progress in recent years. The use of medical databases is a requirement for many medical research groups, as was the case for the team led by Stefánsson in Iceland. A social and political debate has arisen on that island nation about the ethical and legal issues stemming from access to and use of this data, as well as the sale of the resulting products. This debate brings to the fore the need to make decisions regarding issues that affect us all.
dc.format
application/pdf
dc.publisher
Societat Catalana de Biologia
dc.relation
Reproducció del document publicat a: https://doi.org/10.2436/20.1501.02.165
dc.relation
Treballs de la Societat Catalana de Biologia, 2016, vol. 67, p. 28-32
dc.relation
https://doi.org/10.2436/20.1501.02.165
dc.rights
cc-by-nc-nd (c) Boladeras i Cucurella, Margarida, 2016
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Filosofia)
dc.subject
Dades massives
dc.title
Consideracions bioètiques sobre la receca genòmica, l'ús de big data i la comercialització dels descobriments
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
